Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

ClinicalTrials.gov ID: NCT03211247

Public ClinicalTrials.gov record NCT03211247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.

Study identification

NCT ID
NCT03211247
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
DBV Technologies
Industry
Enrollment
414 participants

Conditions and interventions

Conditions

Interventions

  • Part A Viaskin Peanut 250 mcg Biological
  • Part A Viaskin Peanut 100 mcg Biological
  • Part A Placebo Biological
  • Part B Viaskin Peanut 250 mcg Biological
  • Part B Placebo Biological

Biological

Eligibility (public fields only)

Age range
1 Year to 3 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2017
Primary completion
Aug 19, 2019
Completion
Apr 26, 2022
Last update posted
Dec 15, 2024

2017 – 2022

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
University of Arizona Health Science Tucson Arizona 85719
Arkansas Children's Hospital Little Rock Arkansas 72202
University of California School of Medicine Los Angeles California 10833
University of California, Rady Children's Hospital San Diego California 92123
University of California San Francisco San Francisco California 94158
Stanford University School of Medicine Stanford California 94305
Children's Hospital Colorado Aurora Colorado 80045
Children's national Health System Washington D.C. District of Columbia 20010
Emory University Atlanta Georgia 30329
Ann & Robert H. Lurie Children's Hospital of CHicago Chicago Illinois 60611
The Universal of Chicago Medical Center Chicago Illinois 60637
Riley Hospital for Children at Indiana University Indianapolis Indiana 46202
Johns Hopkins Hospital Baltimore Maryland 21205
Boston Childrens' Hospital Boston Massachusetts 02115
University of Michigan Health System Ann Arbor Michigan 48106
Mount Sinai Medical Center New York New York 10029
University of Rochester Rochester New York 14642
The University of North Carolina - Chapell Hill Chapel Hill North Carolina 27599
Cleveland Clinic Cleveland Ohio 44195
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Le Bonheur Children's Hospital Memphis Tennessee 38105
Vanderbilt University Medical Center Nashville Tennessee 37232
Dell Children's Medical Center Austin Texas 78723
Children's Medical Center of Dallas Dallas Texas 75235
Baylor College of Medicine - Texas Children's Hospital Houston Texas 77030
ASTHMA, Inc. Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03211247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03211247 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →